SCHEMBL7201836

SCHEMBL7201836

COc1ccccc1OC1C(=O)N=C(C(F)(F)F)NC1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA4 P22748 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34
CYP3A4 P08684 1/20 0.33
ESRRA P11474 1/20 0.33
ELANE P08246 1/20 0.33
PDE4D Q08499 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7293888 0.77 CA12 (0.35) CA12CA1CA2CA4CA7
SCHEMBL7303598 0.77 CA12 (0.35) CA12CA1CA2CA4CA7
SCHEMBL7296783 0.76 DDB1 (0.37) CA12CA1CA2CA4CA7
SCHEMBL627191 0.76 RAB9A (0.35) CA12CA1CA2CA4CA7
SCHEMBL7330474 0.74 MAPT (0.33) CA12CA1CA2CA4CA7
SCHEMBL7209808 0.74 CA2 (0.46) CA12CA1CA2CA4CA7
SCHEMBL8323450 0.73 STK10 (0.41) KDM4EALDH1A1GAACYP3A4TDP1
SCHEMBL7303932 0.73 ALDH1A1 (0.40) KDM4EALDH1A1GLAGAACYP3A4
SCHEMBL7297774 0.72 FYN (0.39) KDM4EALDH1A1GLACYP3A4TDP1
SCHEMBL7293097 0.72 STK10 (0.40) CYP3A4STK10SLK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596719-B1 Manufacturing those compounds, pharmaceutical compositions containing one or more of those compounds as endothelin antagonists, and a method of treating a subject having a disorder involving endothelin with the compounds of the ACTELIO PHARMACEUTICALS LTD. (CH) 2003-07-22 US disclosed
EP-1137642-A1 BIS-SULFONAMIDES Actelion Pharmaceuticals Ltd. (CH) 2001-10-04 EP disclosed
WO-2001017976-A1 BIS-SULFONAMIDES ACTELION PHARMACEUTICALS LTD (CH) 2001-03-15 WO disclosed